Do tumor-necrosis-factor inhibitors prevent first cardiovascular events in patients with rheumatoid arthritis?

scientific article published on 01 December 2005

Do tumor-necrosis-factor inhibitors prevent first cardiovascular events in patients with rheumatoid arthritis? is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/NCPRHEUM0066
P698PubMed publication ID16932633

P2093author name stringMariana J Kaplan
P2860cites workCardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritisQ34182804
Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritisQ44187483
Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout miceQ45042448
Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients.Q50701881
High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factorsQ77406810
P433issue2
P921main subjectrheumatoid arthritisQ187255
P304page(s)74-75
P577publication date2005-12-01
P1433published inNature Clinical Practice RheumatologyQ15752269
P1476titleDo tumor-necrosis-factor inhibitors prevent first cardiovascular events in patients with rheumatoid arthritis?
P478volume1

Search more.